Heartbroken patients even with extension of the Soliris benefit

The health insurance standard of ‘Soliris (eculizumab)’, the only domestic PHN (paroxismal nocturnal hemoglobinuria) treatment, has been extended since the 1st. Now, patients who are pregnant up to 3 months after childbirth can be prescribed for Soliris with no relation of patients’ transfusion.

However, the problem is that the term only last until 3 months after giving birth. Then, payment st...